Lipocine (LPCN) Return on Assets [ROA] (2012 - 2025)
Lipocine's Return on Assets [ROA] was -31.60% in Q3 2025, down 13.05 percentage points from -18.55% a year earlier and down 8.53 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Return on Assets [ROA] (2012 - 2025) Analysis & Trends
For FY2024, Return on Assets [ROA] at Lipocine came in at 0.04%, up 54.05 percentage points from FY2023.
- Return on Assets [ROA] shows a five-year change of +64.25 percentage points (FY2019 to FY2024).
- In earlier years, Return on Assets [ROA] was -54.02% in FY2023 (-30.12 pp), -23.90% in FY2022 (-22.27 pp), -1.63% in FY2021 (+91.52 pp) and -93.15% in FY2020 (-28.94 pp).
- The Q3 2025 figure marks the lowest quarterly Return on Assets [ROA] since Q2 2024.
- Compared with a year earlier, Return on Assets [ROA] was higher in five of the last eight quarters, with an average year-over-year change of +9.49 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2021 (a gain of 82.32 percentage points); the worst was Q3 2023 (a drop of 69.05 percentage points).
- Per Business Quant data, LPCN's Return on Assets [ROA] in the three quarters before Q3 2025 was -23.07% (Q2 2025), -24.97% (Q1 2025) and 0.04% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Lipocine | 11.11 Mn | -56.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -31.60% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | -24.97% |
| Dec 31, 2024 | 0.04% |
| Sep 30, 2024 | -18.55% |
| Jun 30, 2024 | -35.02% |
| Mar 31, 2024 | -37.02% |
| Dec 31, 2023 | -68.49% |
| Sep 30, 2023 | -59.02% |
| Jun 30, 2023 | -37.39% |
| Mar 31, 2023 | -31.14% |
| Dec 31, 2022 | -27.96% |
| Sep 30, 2022 | 10.04% |
| Jun 30, 2022 | 7.62% |
| Mar 31, 2022 | -1.51% |
| Dec 31, 2021 | -1.37% |
| Sep 30, 2021 | -40.58% |
| Jun 30, 2021 | -38.88% |
| Mar 31, 2021 | -48.89% |
| Dec 31, 2020 | -83.68% |
API Access
Lipocine Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();